AbbVie
ABBV
$10.56 (-5.62%)
1D
1W
3M
1Y
5Y
ALL
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie Read More...Read Less
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Seeking Alpha • 9 hours ago • ABBV
Dividend Checkup Amid Trump Drug Pricing Order: I Prefer AbbVie Over PfizerSeeking Alpha • 11 hours ago • ABBV
AbbVie Inc. (ABBV) Presents at BofA Securities 2025 Healthcare Conference (Transcript)CNBC Television • 1 day ago • ABBV
Calls of the Day: RobinHood, UnitedHealth, Abbvie and Lowe'sAccesswire • 1 day ago • ABBV
Lost Money on Cerevel Therapeutics Holdings, Inc. (ABBV)? Contact Levi & Korsinsky Before June 3, 2025 to Join Class ActionReuters • 1 day ago • ABBV
US FDA approves AbbVie's drug for a type of lung cancerCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.